Literature DB >> 11890334

Lymph node metastases in gastric cancer: correlation between new and old UICC TNM classification.

M Omejc1, R Juvan, F Jelenc, S Repse.   

Abstract

The 5th edition of TNM classification (1997) grades lymph node involvement in gastric cancer by the number of metastatic lymph nodes. Their prognostic significance as defined by the new (5th edn., 1997) and old (4th edn., 1987) TNM classification was evaluated and survival in pN categories between both versions was compared. It was demonstrated in our analysis that comparison of old and new TNM systems is possible. Categories pN1 and pN2 contain patients selected by different criteria in both versions of TNM classification but with similar survival probabilities. Anatomic location of lymph nodes as described in the 4th edn. and number of involved nodes in the 5th edn. of TNM classification have about the same prognostic value in categories pN1 and pN2. The advantage of the 5th edn. is the identification of a group of patients (pN3, >15 involved lymph nodes) with significantly poor prognosis, which, in our series, includes 15% of R0 resected patients with lymph node metastases.

Entities:  

Mesh:

Year:  2001        PMID: 11890334

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  9 in total

1.  The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification.

Authors:  Sumin Chae; Anbok Lee; Joo-Ho Lee
Journal:  Gastric Cancer       Date:  2011-03-01       Impact factor: 7.370

2.  Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.

Authors:  Kazumasa Fujitani; Kenichi Nakamura; Jyunki Mizusawa; Takeshi Kuwata; Tadakazu Shimoda; Hiroshi Katayama; Ryoji Kushima; Hirokazu Taniguchi; Takaki Yoshikawa; Narikazu Boku; Masanori Terashima; Haruhiko Fukuda; Takeshi Sano; Mitsuru Sasako
Journal:  Gastric Cancer       Date:  2020-06-22       Impact factor: 7.370

3.  Old and new TNM in carcinoma of the gastric antrum: analysis of our personal experience.

Authors:  Paolo Del Rio; Paolo Dell'Abate; Paolo Soliani; Maria Francesca Arcuri; Sara Tacci; Stefanie Ziegler; Mario Sianesi
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

4.  Sentinel node mapping during laparoscopic distal gastrectomy for gastric cancer.

Authors:  E Orsenigo; V Tomajer; S Di Palo; L Albarello; C Doglioni; E Masci; E Viale; C Staudacher
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

Review 5.  Clinical significance of lymph node metastasis in gastric cancer.

Authors:  Jing-Yu Deng; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

6.  Correlation of tumor-positive ratio and number of perigastric lymph nodes with prognosis of patients with surgically-removed gastric carcinoma.

Authors:  Yong-Bin Ding; Guo-Yu Chen; Jian-Guo Xia; Xi-Wei Zang; Hong-Yu Yang; Li Yang; Yue-Xian Liu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

7.  Role of computer analysis in gastric cancer surgery: evaluation of the WinEstimate v. 2.5 computer program.

Authors:  Mirko Omejc; Jernej Mekicar
Journal:  World J Surg       Date:  2003-12-05       Impact factor: 3.352

8.  OCT3/4 expression is correlated with the invasion of gastric carcinoma.

Authors:  Na Li; Weiqiang Wang; Bin Xu; Hongyun Gong
Journal:  Oncol Lett       Date:  2014-05-07       Impact factor: 2.967

9.  Anatomical location-based nodal staging system is superior to the 7th edition of the American Joint Committee on Cancer staging system among patients with surgically resected, histologically low-grade gastric cancer: A single institutional experience.

Authors:  Mei-Wen Chen; Chien-Pin Chan; Yih-Jeng Lin; Hsu-Heng Yen
Journal:  PLoS One       Date:  2019-02-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.